CBIH Pursues Regulatory Compliance and Market Growth with Essential Licensing Applications
July 15, 2024 08:00 ET
|
CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
Cannabis Bioscience International Holdings (OTCMKTS:CBIH) has initiated a strategic move to expand its presence in the cannabis market by filing applicati
CBIH Charts Path to Future Leadership in Cannabis Medicine
July 08, 2024 08:00 ET
|
CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
A letter from our desk HOUSTON, July 08, 2024 (GLOBE NEWSWIRE) -- Since the start of the year, Cannabis Bioscience International Holdings (OTCMKTS: CBIH) has embarked on a transformative journey...
CBIH advances Cancer Care with Novel Cannabis Patents for Breast and Pancreatic Cancers
July 01, 2024 08:00 ET
|
CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
Cannabis Bioscience International Holdings (OTCMKTS: CBIH) is excited to announce the submission of our inaugural pair of patents, focusing on novel treatm
CBIH Announces Strategic Advancements Initiated by Recently Appointed Director, Setting a New Paradigm and Driving Visionary Change
June 26, 2024 10:52 ET
|
CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
As CBIH prepares for the manufacturing and distribution of its products, the potential collaboration might involve this entity acting as CBIH's distributor
Unleashing the Potential of Cannabis: Cannabis Bioscience International Holdings Reaches a Historic Valuation
June 17, 2024 09:50 ET
|
CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
CBIH a company dedicated to medicinal cannabis research for over 15 years, has achieved a 2 billion dollar valuation.
CBIH and Vita Biotech Forge Alliance to Propel Clinical Studies Forward
June 05, 2024 15:12 ET
|
CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
“Collaboration in clinical trials ensures data integrity and safety, advancing both organizations' missions and improving patient care,” says Dr. Jennifer
Cannabis Bioscience International Holdings Announces Effectiveness of Form S-1 Registration Statement
December 06, 2023 09:00 ET
|
Cannabis Bioscience International Holdings, Inc.
HOUSTON, TX , Dec. 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH) announces that its registration statement on Form S-1 (File...
Cannabis Bioscience International Holdings (CBIH) Unveils Its Rebranding Through Its New and Innovative Website
September 11, 2023 09:30 ET
|
Cannabis Bioscience International Holdings, Inc.
HOUSTON, Texas, Sept. 11, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Cannabis Bioscience International Holdings (trading on the OTC Markets under the ticker symbol CBIH), a medical research...
FINRA Announces Approval for Corporate Name Change From China Infrastructure Construction Corp. to Cannabis Bioscience International Holdings and Ticker Symbol Change from CHNC to CBIH
August 21, 2023 09:00 ET
|
Cannabis Bioscience International Holdings, Inc.
HOUSTON, Texas, Aug. 21, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Cannabis Bioscience International Holdings (the “Company”) a diversified medical and educational company with a particular focus...
CBIH Announces the Completion of the “Phase of Research and Discovery" for Its Phytotherapy Cancer Scientific Project
May 01, 2023 09:00 ET
|
Cannabis Bioscience International Holdings, Inc.
HOUSTON, TX, May 01, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- CBIH, previously known as CHNC, and trading under the ticker symbol CHNC, announces the completion of the stage “research and...